The phosphatidylinositol-3-kinase inhibitor PX-866 overcomes resistance to the epidermal growth factor receptor inhibitor gefitinib in A-549 human non–small cell lung cancer xenografts
暂无分享,去创建一个
P. Wipf | G. Paine-Murrieta | D. Kirkpatrick | G. Powis | R. Abraham | A. Baker | Nathan T Ihle | M. Berggren | W. Tate | N. Ihle